Two Parallel Randomized News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life when compared to baseline Clinically important improvements seen for all.

British columbiaUnited kingdomJodi regtsChristopher kenneyIan mortimerXenon pharmaceuticals incXenon pharmaceuticalsInternational epilepsy congressExchange commissionSecurities exchangeSeizure worrySocial functioningMedication effectsChief executive officerChief medical officerLife improvements